Molecular Partners AG

MOLN Stock Healthcare Biotechnology
$3.56
-0.09 (-2.47%)
Price as of Oct 16, 2026 market close

Performance

1 Month
-9.2%
3 Months
-11.0%
YTD
-18.3%
1 Year
-6.6%
3 Year annualized
-3.3%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
54.8%
Largest decline max drawdown, since Oct 2021
-89.6%
Risk-adjusted return Sharpe ratio, 1-year
0.15

Own MOLN?

See how MOLN contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.